-
November 07, 2018
9:15 pm Europe/London
VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
-
October 31, 2018
9:15 pm Europe/London
VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
-
October 04, 2018
2:15 pm Europe/London
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
-
September 26, 2018
2:15 pm Europe/London
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
-
August 13, 2018
9:15 pm Europe/London
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
-
August 13, 2018
2:15 pm Europe/London
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
-
August 09, 2018
2:15 pm Europe/London
VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
-
August 08, 2018
11:15 am Europe/London
VolitionRx Announces $9 Million Private Placement
-
August 07, 2018
2:15 pm Europe/London
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
-
August 01, 2018
12:15 pm Europe/London
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today